Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily L MacLean

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Med (New York, N.Y.)|February 16, 2022
Integrated testing for TB and COVID-19Emily L MacLean, Luz Villa-Castillo, Morten Ruhwald, et al.
Journal of Clinical Microbiology|October 24, 2024
Host blood protein biomarkers to screen for tuberculosis disease: a systematic review and meta-analysisMary Gaeddert, Kerstin Glaser, Bih H Chendi, et al.
Diagnostic and Prognostic Research|June 15, 2022
Bayesian latent class analysis produced diagnostic accuracy estimates that were more interpretable than composite reference standards for extrapulmonary tuberculosis testsEmily L MacLean, Mikashmi Kohli, Lisa Köppel, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 25, 2026
Biomarker tests of progression from tuberculosis infection to disease: a systematic reviewKylie Tingley, Angela Li, Emily L MacLean, et al.
The Lancet. Infectious Diseases|July 6, 2024
The inclusion of children and adolescents in tuberculosis diagnostic development and evaluation-a consensus statementElse M Bijker, Lyn Horn, Sylvia LaCourse, et al.
The Lancet. Global Health|February 19, 2026
The tuberculogenic environmentMikaela Coleman, Claire J Calderwood, Sian Magee, et al.
The New England Journal of Medicine|December 18, 2024
Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis in VietnamGreg J Fox, Nguyen Viet Nhung, Nguyen Cam Binh, et al.
Bulletin of the World Health Organization|November 14, 2023
Target product profiles: tests for tuberculosis treatment monitoring and optimizationAnkur Gupta-Wright, Saskia den Boon, Emily L MacLean, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Med (New York, N.Y.)|February 16, 2022
Integrated testing for TB and COVID-19Emily L MacLean, Luz Villa-Castillo, Morten Ruhwald, et al.
Journal of Clinical Microbiology|October 24, 2024
Host blood protein biomarkers to screen for tuberculosis disease: a systematic review and meta-analysisMary Gaeddert, Kerstin Glaser, Bih H Chendi, et al.
Diagnostic and Prognostic Research|June 15, 2022
Bayesian latent class analysis produced diagnostic accuracy estimates that were more interpretable than composite reference standards for extrapulmonary tuberculosis testsEmily L MacLean, Mikashmi Kohli, Lisa Köppel, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 25, 2026
Biomarker tests of progression from tuberculosis infection to disease: a systematic reviewKylie Tingley, Angela Li, Emily L MacLean, et al.
The Lancet. Infectious Diseases|July 6, 2024
The inclusion of children and adolescents in tuberculosis diagnostic development and evaluation-a consensus statementElse M Bijker, Lyn Horn, Sylvia LaCourse, et al.
The Lancet. Global Health|February 19, 2026
The tuberculogenic environmentMikaela Coleman, Claire J Calderwood, Sian Magee, et al.
The New England Journal of Medicine|December 18, 2024
Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis in VietnamGreg J Fox, Nguyen Viet Nhung, Nguyen Cam Binh, et al.
Bulletin of the World Health Organization|November 14, 2023
Target product profiles: tests for tuberculosis treatment monitoring and optimizationAnkur Gupta-Wright, Saskia den Boon, Emily L MacLean, et al.
Pageof 1